{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:52:41Z","timestamp":1791924761955,"version":"4.3.4"},"reference-count":7,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["EY001792"],"award-info":[{"award-number":["EY001792"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ophthalmologyscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Science"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.xops.2026.101076","type":"journal-article","created":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T06:26:43Z","timestamp":1768717603000},"page":"101076","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association between Dupilumab and Ocular Surface Diseases in Children"],"prefix":"10.1016","volume":"6","author":[{"given":"Mohammad","family":"Ayoubi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taher K.","family":"Eleiwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Anthony","family":"Chacko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Pemberton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajirah N.","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul H.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelrahman M.","family":"Elhusseiny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3 Suppl 1","key":"10.1016\/j.xops.2026.101076_bib1","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.jaad.2017.12.022","article-title":"Dupilumab: a review of its use in the treatment of atopic dermatitis","volume":"78","author":"Gooderham","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.xops.2026.101076_bib2","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.3390\/jcm14072487","article-title":"Ocular side effects of dupilumab: a comprehensive overview of the literature","volume":"14","author":"Boscia","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.xops.2026.101076_bib3","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/pde.15814","article-title":"Dupilumab-associated ocular surface disease in pediatric atopic dermatitis: a single-center Asian experience","volume":"42","author":"Yap","year":"2024","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.xops.2026.101076_bib4","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/cea.70025","article-title":"Dupilumab-associated ocular surface disease in paediatric atopic dermatitis patients: results from the BioDay registry","volume":"55","author":"van der Rijst","year":"2025","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.xops.2026.101076_bib5","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1002\/jvc2.528","article-title":"Dupilumab-related ocular surface disorders in a paediatric cohort with atopic dermatitis, treated in a tertiary paediatric hospital in London","volume":"3","author":"Rampersad","year":"2024","journal-title":"JEADV Clin Pract"},{"key":"10.1016\/j.xops.2026.101076_bib6","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s13555-025-01367-5","article-title":"Incidence of conjunctivitis and keratitis among individuals with moderate-to-severe atopic dermatitis treated with dupilumab in the United States: a cohort study in routine care based on healthcare claims","volume":"15","author":"Franklin","year":"2025","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.xops.2026.101076_bib7","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1111\/all.15326","article-title":"IL-4 and IL-13 both contribute to the homeostasis of human conjunctival goblet cells in vitro","volume":"77","author":"Hansen","year":"2022","journal-title":"Allergy"}],"container-title":["Ophthalmology Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266691452600014X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266691452600014X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T12:25:38Z","timestamp":1777638338000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266691452600014X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":7,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S266691452600014X"],"URL":"https:\/\/doi.org\/10.1016\/j.xops.2026.101076","relation":{},"ISSN":["2666-9145"],"issn-type":[{"value":"2666-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between Dupilumab and Ocular Surface Diseases in Children","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xops.2026.101076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 by the American Academy of Ophthalmology.","name":"copyright","label":"Copyright"}],"article-number":"101076"}}